Journal article icon

Journal article

Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices

Abstract:
Background: Routine echocardiographic monitoring is recommended in muscular dystrophy patients to detect left ventricular systolic dysfunction (LVSD) but is often challenging due to physical limitations. This study evaluates whether artificial intelligence-based electrocardiogram interpretation (AI-ECG) can detect and predict LVSD in muscular dystrophy patients. Methods: Patients aged >16 years who underwent an ECG and echocardiogram within 90 days at the University Medical Center Utrecht were included. Patients with Duchenne (DMD), Becker (BMD), limb-girdle muscular dystrophy (LGMD). myotonic dystrophy (MD), and female DMD/BMD carriers, were identified. A convolutional neural network (CNN) was trained on a derivation cohort of patients without muscular dystrophy to detect LVSD and tested on muscular dystrophy patients. A Cox proportional hazards model assessed AI-ECG's predictive value for new-onset LVSD. Results: The derivation cohort included 53,874 ECG-echocardiogram pairs from 30,978 patients, while the muscular dystrophy test set comprised 390 ECG-echo pairs from 390 patients. LVSD prevalence varied from 81.3 % in DMD to 13.4 % in MD. The model achieved an AUROC of 0.83 (0.79–0.87) in the muscular dystrophy test set, with sensitivity 0.87 (0.81–0.93), specificity 0.58 (0.52–0.63), NPV 0.91 (0.86–0.95), and PPV 0.49 (0.43–0.56). AI-ECG predicted new-onset LVSD with an AUROC of 0.72 (0.66–0.78), with AI-ECG probability being a significant predictor. Conclusions: AI-ECG can detect LVSD in muscular dystrophy patients, offering a non-invasive, accessible tool for risk stratification and an alternative to routine echocardiography. It may also predict new-onset LVSD, enabling earlier intervention. Further research should explore external validation, pediatric application, and integration within the clinical care plan.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Role:
Author
ORCID:
0000-0003-3812-3260
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-8524-1203
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4362-0720
More by this author
Role:
Author
ORCID:
0000-0002-5664-4126
More by this author
Role:
Author
ORCID:
0000-0003-3197-2657



Publisher:
Nature Research
Journal:
npj Digital Medicine More from this journal
Volume:
6
Issue:
1
Pages:
124-124
Article number:
124
Publication date:
2023-07-11
DOI:
EISSN:
2398-6352
ISSN:
2398-6352


Language:
English
Keywords:
Pubs id:
1493849
Local pid:
pubs:1493849
Source identifiers:
W4383911793
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP